APA (7th ed.) Citation

Xingyun Liu, Yanling Ren, Shuanglin Qin, & Zerui Yang. (2024). Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation. BMC.

Chicago Style (17th ed.) Citation

Xingyun Liu, Yanling Ren, Shuanglin Qin, and Zerui Yang. Exploring the Mechanism of 6-Methoxydihydrosanguinarine in the Treatment of Lung Adenocarcinoma Based on Network Pharmacology, Molecular Docking and Experimental Investigation. BMC, 2024.

MLA (9th ed.) Citation

Xingyun Liu, et al. Exploring the Mechanism of 6-Methoxydihydrosanguinarine in the Treatment of Lung Adenocarcinoma Based on Network Pharmacology, Molecular Docking and Experimental Investigation. BMC, 2024.